Differential inhibition of histamine release from mast cells by protein kinase C inhibitors: staurosporine and K-252a.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Biochemical Pharmacology

• Publication date

  1990-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-2952(90)90542-SPMID 1696482
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Studies of protein kinase C in the rat basophilic leukemia (RBL-2H3) cell reveal that antigen-induced signals are not mimicked by the actions of phorbol myristate acetate and Ca2+ ionophore.

  1989cited by this paper
• Effects of a protein kinase C inhibitor, K-252a, on human polymorphonuclear neutrophil responsiveness.

  1988cited by this paper
• Stimulus-dependent inhibition of platelet aggregation by the protein kinase C inhibitors polymyxin B, H-7 and staurosporine.

  1988cited by this paper
• Sequence analysis of cDNA and genomic DNA for a putative pertussis toxin-insensitive guanine nucleotide-binding regulatory protein alpha subunit.

  1988cited by this paper
• K252a, a new inhibitor of protein kinase C, concomitantly inhibits 40K protein phosphorylation and serotonin secretion in a phorbol ester-stimulated platelets.

  1987cited by this paper
• K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic nucleotide-dependent protein kinases.

  1987cited by this paper
• Effects of ADP-ribosylation of GTP-binding protein by pertussis toxin on immunoglobulin E-dependent and -independent histamine release from mast cells and basophils.

  1987cited by this paper
• Immunological evidence for two physiological forms of protein kinase C

  1987cited by this paper
• Translocation of protein kinase C is not required to inhibit the antigen-induced increase of cytosolic calcium in a mast cell line.

  1987cited by this paper
• Redistribution of phospholipid/Ca2+-dependent protein kinase in mast cells activated by various agonists.

  1987cited by this paper
• The structures of the novel protein kinase C inhibitors K-252a, b, c and d.

  1986cited by this paper
• K-252b, c and d, potent inhibitors of protein kinase C from microbial origin.

  1986cited by this paper
• K-252a, a potent inhibitor of protein kinase C from microbial origin.

  1986cited by this paper
• Protein kinase C phosphorylates human platelet inositol trisphosphate 5'-phosphomonoesterase, increasing the phosphatase activity.

  1986cited by this paper
• Effect of the tridecamer of compound 48/80, a Ca2+-dependent histamine releaser, on phospholipid metabolism during the early stage of histamine release from rat mast cells.

  1986cited by this paper
• Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase.

  1986cited by this paper
• Isozymic forms of rat brain Ca2+-activated and phospholipid-dependent protein kinase.

  1986cited by this paper
• Antigen-induced increase in protein kinase C activity in plasma membrane of mast cells.

  1985cited by this paper
• Synergistic action of protein kinase C and calcium for histamine release from rat peritoneal mast cells.

  1984cited by this paper
• Direct demonstration of increased intracellular concentration of free calcium as measured by quin-2 in stimulated rat peritoneal mast cell.

  1984cited by this paper
• Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate

  1983cited by this paper
• Decrease in cytosolic calcium/phospholipid-dependent protein kinase activity following phorbol ester treatment of EL4 thymoma cells.

  1982cited by this paper
• Effect of anti-allergic compounds on anaphylactic histamine secretion from rat peritoneal mast cells in the presence and absence of exogenous calcium.

  1982cited by this paper
• The Robert A. Cooke memorial lecture. Analysis of triggering events in mast cells for immunoglobulin E-mediated histamine release.

  1981cited by this paper
• Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover.

  1980cited by this paper
• Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells.

  1979cited by this paper
• IgE-induced changes in human basophil cyclic AMP levels.

  1978cited by this paper
• Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

  1977cited by this paper
• The site of action of the histamine releaser compound 45/80 in causing mast cell degranulation.

  1977cited by this paper
• Pharmacologic modulation of inflammatory mediator release by rat mast cells.

  1976cited by this paper
• Modulation of cyclic AMP in purified rat mast cells. III. Studies on the effects of concanavalin A and anti-IgE on cyclic AMP concentrations during histamine release.

  1975cited by this paper
• High resolution two-dimensional electrophoresis of proteins.

  1975cited by this paper

• Mast Cell Effects on Esophageal Smooth Muscle and their Potential Role in Eosinophilic Esophagitis and Achalasia.

  2020cites this paper
• Receptor signaling in immune cell development and function

  2011cites this paper
• Arthropod-Derived Histamine-Binding Protein Prevents Murine Allergic Asthma

  2004influential citation
• Urinary trypsin inhibitor reduces the release of histamine from rat peritoneal mast cells.

  1998cites this paper
• Heterogeneity of human skin mast cells and human basophils. I. Pharmacological experiments with activators and inhibitors of protein kinase C.

  1996cites this paper
• The antineoplastic bryostatins affect human basophils and mast cells differently.

  1995cites this paper
• Staurosporine, a protein kinase inhibitor, increases the intoxicating potencies of ethanol and other n-alkanols in Rana pipiens tadpoles.

  1995cites this paper
• Mechanism of histamine release by endothelin-1 distinct from that by antigen in mouse bone marrow-derived mast cells.

  1995cites this paper
• Evidence that Prostaglandin E2 Can Block Calcium‐Activated 86Rb Efflux from Rat Brain Synaptosomes via a Protein Kinase C‐Dependent Mechanism

  1994cites this paper
• Pharmacological Evidence for the Involvement of Calciuml Calmodulin in Serotonin 5‐HT3 Receptor‐Mediated Cation Permeability in NG 108‐15 Cells

  1994cites this paper
• Staurosporine inhibits the anaphylactic reaction of the isolated guinea-pig heart.

  1994cites this paper
• Antigenic and Peptidergic Pathways of Mast Cell Activation

  1993cites this paper
• Inhibition of histamine release from mast cells by nigellone.

  1993cites this paper
• Staurosporine, a Protein Kinase C Inhibitor, Decreases the General Anesthetic Requirement in Rana pipiens Tadpoles

  1993cites this paper
• CGP 41251, a novel protein kinase inhibitor with in vitro selectivity for protein kinase C, strongly inhibits immunological activation of human skin mast cells and human basophils.

  1993cites this paper
• Protein kinase C: a target for anti-inflammatory therapy?

  1992cites this paper
• The roles of calmodulin and protein kinase C in histamine secretion from mast cells.

  1992cites this paper
• Influence of protein kinase C, cAMP and phosphatase activity on histamine release produced by compound 48/80 and sodium fluoride on rat mast cells

  1992cites this paper
• Pharmacological studies on the role of protein kinase C in signal transduction of human basophils.

  1992cites this paper
• Ca(2+)-induced translocation of protein kinase C during Ca(2+)-dependent histamine release from beta-escin-permeabilized rat mast cells.

  1992cites this paper
• Influence of staurosporine on glucose-mediated and glucose-conditioned insulin secretion.

  1991cites this paper
• Enzymatic dispersion of mast cells from human sinus mucosa: characterization of histamine release and its comparison with chopped fragments of the tissue.

  1991cites this paper
• Pharmaceutical applications

  1991cites this paper
• In vitro effects of bryostatin 1 on the metabolism and cytotoxicity of 1-beta-D-arabinofuranosylcytosine in human leukemia cells.

  1991cites this paper